Dénes Bánhegyi

Learn More
BACKGROUND The GIHU004 study was designed to evaluate the safety and immunogenicity of three doses of DermaVir immunization in HIV-infected subjects on fully suppressive combination antiretroviral therapy (cART). METHODOLOGY/PRINCIPAL FINDINGS This first-in-human dose escalation study was conducted with three topical DermaVir doses targeted to epidermal(More)
  • 1